Clinical Trial Update: Neuroprotection of Memantine and Rosuvastatin [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial investigating memantine and rosuvastatin for peripheral neuropathy is in Phase 2 and Phase 3 but not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Neuropathy

Drugs mentioned

• Memantine (memantine)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Tanta University | Conditions: Peripheral Nerve Disease | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING